(+)-Nutlin-3 |
The less active enantiomer of (-)-nutlin-3; inhibits the interaction betwe… |
10 mg |
10009816-10 |
More Info
|
(+)-Nutlin-3 |
The less active enantiomer of (-)-nutlin-3; inhibits the interaction betwe… |
25 mg |
10009816-25 |
More Info
|
(+)-Nutlin-3 |
The less active enantiomer of (-)-nutlin-3; inhibits the interaction betwe… |
5 mg |
10009816-5 |
More Info
|
NV-5138 |
A sestrin modulator and mTORC1 activator; binds to sestrin 2 (Kd = 1.49 &m… |
1 mg |
35482-1 |
More Info
|
NV-5138 |
A sestrin modulator and mTORC1 activator; binds to sestrin 2 (Kd = 1.49 &m… |
10 mg |
35482-10 |
More Info
|
NV-5138 |
A sestrin modulator and mTORC1 activator; binds to sestrin 2 (Kd = 1.49 &m… |
5 mg |
35482-5 |
More Info
|
NV-5138 |
A sestrin modulator and mTORC1 activator; binds to sestrin 2 (Kd = 1.49 &m… |
500 µg |
35482-500 |
More Info
|
NVP-2 |
A Cdk9 / cyclin T1 complex inhibitor; selective for the Cdk9 / cyclin T1 c… |
1 mg |
34725-1 |
More Info
|
NVP-2 |
A Cdk9 / cyclin T1 complex inhibitor; selective for the Cdk9 / cyclin T1 c… |
10 mg |
34725-10 |
More Info
|
NVP-2 |
A Cdk9 / cyclin T1 complex inhibitor; selective for the Cdk9 / cyclin T1 c… |
25 mg |
34725-25 |
More Info
|
NVP-2 |
A Cdk9 / cyclin T1 complex inhibitor; selective for the Cdk9 / cyclin T1 c… |
5 mg |
34725-5 |
More Info
|
NVP-231 |
A potent and reversible inhibitor of ceramide kinase (IC50 = 12 nM); selec… |
1 mg |
13858-1 |
More Info
|
NVP-231 |
A potent and reversible inhibitor of ceramide kinase (IC50 = 12 nM); selec… |
10 mg |
13858-10 |
More Info
|
NVP-231 |
A potent and reversible inhibitor of ceramide kinase (IC50 = 12 nM); selec… |
25 mg |
13858-25 |
More Info
|
NVP-231 |
A potent and reversible inhibitor of ceramide kinase (IC50 = 12 nM); selec… |
5 mg |
13858-5 |
More Info
|
NVP-AAM077 |
An NMDA receptor antagonist (IC50 = 0.008 µM); selective for NMDA re… |
1 mg |
30622-1 |
More Info
|
NVP-AAM077 |
An NMDA receptor antagonist (IC50 = 0.008 µM); selective for NMDA re… |
10 mg |
30622-10 |
More Info
|
NVP-AAM077 |
An NMDA receptor antagonist (IC50 = 0.008 µM); selective for NMDA re… |
25 mg |
30622-25 |
More Info
|
NVP-AAM077 |
An NMDA receptor antagonist (IC50 = 0.008 µM); selective for NMDA re… |
5 mg |
30622-5 |
More Info
|
NVP-ACC789 |
An inhibitor of VEGFRs (IC50s = 0.38, 0.02, 0.18, and 0.23 µM for hu… |
1 mg |
23458-1 |
More Info
|
NVP-ACC789 |
An inhibitor of VEGFRs (IC50s = 0.38, 0.02, 0.18, and 0.23 µM for hu… |
10 mg |
23458-10 |
More Info
|
NVP-ACC789 |
An inhibitor of VEGFRs (IC50s = 0.38, 0.02, 0.18, and 0.23 µM for hu… |
5 mg |
23458-5 |
More Info
|
NVP-ADW742 |
A selective IGF-1R inhibitor (IC50 = 0.17 µM); inhibits tumor prolif… |
1 mg |
18390-1 |
More Info
|
NVP-ADW742 |
A selective IGF-1R inhibitor (IC50 = 0.17 µM); inhibits tumor prolif… |
10 mg |
18390-10 |
More Info
|
NVP-ADW742 |
A selective IGF-1R inhibitor (IC50 = 0.17 µM); inhibits tumor prolif… |
5 mg |
18390-5 |
More Info
|
NVP-ADW742 |
A selective IGF-1R inhibitor (IC50 = 0.17 µM); inhibits tumor prolif… |
50 mg |
18390-50 |
More Info
|
NVP-AEW541 |
An IGF-1R inhibitor (IC50 = 0.15 µM in a cell-free assay); selective… |
10 mg |
33946-10 |
More Info
|
NVP-AEW541 |
An IGF-1R inhibitor (IC50 = 0.15 µM in a cell-free assay); selective… |
25 mg |
33946-25 |
More Info
|
NVP-AEW541 |
An IGF-1R inhibitor (IC50 = 0.15 µM in a cell-free assay); selective… |
5 mg |
33946-5 |
More Info
|
NVP-AEW541 |
An IGF-1R inhibitor (IC50 = 0.15 µM in a cell-free assay); selective… |
50 mg |
33946-50 |
More Info
|
NVP-AEW541 (hydrochloride) |
An IGF-1R inhibitor (IC50 = 0.15 µM in a cell-free assay); selective… |
1 mg |
13641-1 |
More Info
|
NVP-AEW541 (hydrochloride) |
An IGF-1R inhibitor (IC50 = 0.15 µM in a cell-free assay); selective… |
10 mg |
13641-10 |
More Info
|
NVP-AEW541 (hydrochloride) |
An IGF-1R inhibitor (IC50 = 0.15 µM in a cell-free assay); selective… |
5 mg |
13641-5 |
More Info
|
NVP-AEW541 (hydrochloride) |
An IGF-1R inhibitor (IC50 = 0.15 µM in a cell-free assay); selective… |
500 µg |
13641-500 |
More Info
|
NVP-AUY922 |
A Hsp90 inhibitor (IC50 = 21 nM in a FP binding assay) that prevents the p… |
10 mg |
10012698-10 |
More Info
|
NVP-AUY922 |
A Hsp90 inhibitor (IC50 = 21 nM in a FP binding assay) that prevents the p… |
5 mg |
10012698-5 |
More Info
|
NVP-BAG956 |
A dual PDK1 and class I PI3K inhibitor (IC50s = 245, 56, 446, 35, and 117… |
1 mg |
24195-1 |
More Info
|
NVP-BAG956 |
A dual PDK1 and class I PI3K inhibitor (IC50s = 245, 56, 446, 35, and 117… |
10 mg |
24195-10 |
More Info
|
NVP-BAG956 |
A dual PDK1 and class I PI3K inhibitor (IC50s = 245, 56, 446, 35, and 117… |
5 mg |
24195-5 |
More Info
|
NVP-BEP800 |
An Hsp90 inhibitor (IC50 = 58 nM for recombinant human Hsp90β); selec… |
1 mg |
18383-1 |
More Info
|
NVP-BEP800 |
An Hsp90 inhibitor (IC50 = 58 nM for recombinant human Hsp90β); selec… |
10 mg |
18383-10 |
More Info
|
NVP-BEP800 |
An Hsp90 inhibitor (IC50 = 58 nM for recombinant human Hsp90β); selec… |
5 mg |
18383-5 |
More Info
|
NVP-BEP800 |
An Hsp90 inhibitor (IC50 = 58 nM for recombinant human Hsp90β); selec… |
500 µg |
18383-500 |
More Info
|
NVP-BEZ235 |
A dual inhibitor of class I PI3Ks and mTOR (IC50s = 4, 75, 7, and 5 nM, fo… |
100 mg |
10565-100 |
More Info
|
NVP-BEZ235 |
A dual inhibitor of class I PI3Ks and mTOR (IC50s = 4, 75, 7, and 5 nM, fo… |
25 mg |
10565-25 |
More Info
|
NVP-BEZ235 |
A dual inhibitor of class I PI3Ks and mTOR (IC50s = 4, 75, 7, and 5 nM, fo… |
250 mg |
10565-250 |
More Info
|
NVP-BEZ235 |
A dual inhibitor of class I PI3Ks and mTOR (IC50s = 4, 75, 7, and 5 nM, fo… |
50 mg |
10565-50 |
More Info
|
NVP-BEZ235 (hydrochloride) |
A potent dual inhibitor of PI3K and mTOR that is well tolerated, displays… |
10 mg |
21185-10 |
More Info
|
NVP-BEZ235 (hydrochloride) |
A potent dual inhibitor of PI3K and mTOR that is well tolerated, displays… |
100 mg |
21185-100 |
More Info
|
NVP-BEZ235 (hydrochloride) |
A potent dual inhibitor of PI3K and mTOR that is well tolerated, displays… |
25 mg |
21185-25 |
More Info
|
NVP-BEZ235 (hydrochloride) |
A potent dual inhibitor of PI3K and mTOR that is well tolerated, displays… |
50 mg |
21185-50 |
More Info
|
NVP-BGT226 |
A dual PI3K and mTOR inhibitor (EC50s = 4, 63, and 38 nM for PI3Kα,… |
1 mg |
22142-1 |
More Info
|
NVP-BGT226 |
A dual PI3K and mTOR inhibitor (EC50s = 4, 63, and 38 nM for PI3Kα,… |
10 mg |
22142-10 |
More Info
|
NVP-BGT226 |
A dual PI3K and mTOR inhibitor (EC50s = 4, 63, and 38 nM for PI3Kα,… |
25 mg |
22142-25 |
More Info
|
NVP-BGT226 |
A dual PI3K and mTOR inhibitor (EC50s = 4, 63, and 38 nM for PI3Kα,… |
5 mg |
22142-5 |
More Info
|
NVP-BHG712 |
A selective, orally bioavailable inhibitor of EphB4 kinase autophosphoryla… |
1 mg |
18489-1 |
More Info
|
NVP-BHG712 |
A selective, orally bioavailable inhibitor of EphB4 kinase autophosphoryla… |
10 mg |
18489-10 |
More Info
|
NVP-BHG712 |
A selective, orally bioavailable inhibitor of EphB4 kinase autophosphoryla… |
25 mg |
18489-25 |
More Info
|
NVP-BHG712 |
A selective, orally bioavailable inhibitor of EphB4 kinase autophosphoryla… |
5 mg |
18489-5 |
More Info
|
NVP-BKM120 |
An inhibitor of the class I PI3K isoforms p110α (IC50 = 52 nM) and p… |
10 mg |
11587-10 |
More Info
|
NVP-BKM120 |
An inhibitor of the class I PI3K isoforms p110α (IC50 = 52 nM) and p… |
25 mg |
11587-25 |
More Info
|
NVP-BKM120 |
An inhibitor of the class I PI3K isoforms p110α (IC50 = 52 nM) and p… |
5 mg |
11587-5 |
More Info
|
NVP-BKM120 |
An inhibitor of the class I PI3K isoforms p110α (IC50 = 52 nM) and p… |
50 mg |
11587-50 |
More Info
|
NVP-BSK805 (hydrochloride) |
A potent inhibitor of JAK2 that also inhibits the JAK2V617F mutant enzyme… |
1 mg |
16714-1 |
More Info
|
NVP-BSK805 (hydrochloride) |
A potent inhibitor of JAK2 that also inhibits the JAK2V617F mutant enzyme… |
10 mg |
16714-10 |
More Info
|
NVP-BSK805 (hydrochloride) |
A potent inhibitor of JAK2 that also inhibits the JAK2V617F mutant enzyme… |
5 mg |
16714-5 |
More Info
|
NVP-BVU972 |
A Met kinase inhibitor (IC50 = 14 nM); selective for Met over a panel of 6… |
1 mg |
34495-1 |
More Info
|
NVP-BVU972 |
A Met kinase inhibitor (IC50 = 14 nM); selective for Met over a panel of 6… |
10 mg |
34495-10 |
More Info
|
NVP-BVU972 |
A Met kinase inhibitor (IC50 = 14 nM); selective for Met over a panel of 6… |
5 mg |
34495-5 |
More Info
|
NVP-CGM097 |
An inhibitor of the MDM2-p53 interaction (IC50 = 1.7 nM for human MDM2 in… |
1 mg |
29519-1 |
More Info
|
NVP-CGM097 |
An inhibitor of the MDM2-p53 interaction (IC50 = 1.7 nM for human MDM2 in… |
10 mg |
29519-10 |
More Info
|
NVP-CGM097 |
An inhibitor of the MDM2-p53 interaction (IC50 = 1.7 nM for human MDM2 in… |
5 mg |
29519-5 |
More Info
|
NVP-TAE226 |
A FAK inhibitor (IC50 = 5.5 nM) that also inhibits IGF-1R (IC50 = 0.16 &mi… |
1 mg |
17685-1 |
More Info
|
NVP-TAE226 |
A FAK inhibitor (IC50 = 5.5 nM) that also inhibits IGF-1R (IC50 = 0.16 &mi… |
10 mg |
17685-10 |
More Info
|
NVP-TAE226 |
A FAK inhibitor (IC50 = 5.5 nM) that also inhibits IGF-1R (IC50 = 0.16 &mi… |
25 mg |
17685-25 |
More Info
|
NVP-TAE226 |
A FAK inhibitor (IC50 = 5.5 nM) that also inhibits IGF-1R (IC50 = 0.16 &mi… |
5 mg |
17685-5 |
More Info
|
NVP-TNKS656 |
A TNKS2 inhibitor (IC50 = 6 nM); inhibits Wnt ligand-induced signaling in… |
1 mg |
19930-1 |
More Info
|
NVP-TNKS656 |
A TNKS2 inhibitor (IC50 = 6 nM); inhibits Wnt ligand-induced signaling in… |
10 mg |
19930-10 |
More Info
|
NVP-TNKS656 |
A TNKS2 inhibitor (IC50 = 6 nM); inhibits Wnt ligand-induced signaling in… |
5 mg |
19930-5 |
More Info
|
NVP-TNKS656 |
A TNKS2 inhibitor (IC50 = 6 nM); inhibits Wnt ligand-induced signaling in… |
500 µg |
19930-500 |
More Info
|
NVS-CECR2-1 |
A potent and selective inhibitor of CECR2 (IC50 = 0.047 µM by Alpha… |
1 mg |
18316-1 |
More Info
|
NVS-CECR2-1 |
A potent and selective inhibitor of CECR2 (IC50 = 0.047 µM by Alpha… |
10 mg |
18316-10 |
More Info
|
NVS-CECR2-1 |
A potent and selective inhibitor of CECR2 (IC50 = 0.047 µM by Alpha… |
25 mg |
18316-25 |
More Info
|
NVS-CECR2-1 |
A potent and selective inhibitor of CECR2 (IC50 = 0.047 µM by Alpha… |
5 mg |
18316-5 |
More Info
|
NVS-PAK1-1 |
An allosteric inhibitor of PAK1 (Kd = 7 nM); has an IC50 value of 5.2 nM i… |
10 mg |
19964-10 |
More Info
|
NVS-PAK1-1 |
An allosteric inhibitor of PAK1 (Kd = 7 nM); has an IC50 value of 5.2 nM i… |
25 mg |
19964-25 |
More Info
|
NVS-PAK1-1 |
An allosteric inhibitor of PAK1 (Kd = 7 nM); has an IC50 value of 5.2 nM i… |
5 mg |
19964-5 |
More Info
|
NVS-PAK1-C |
A negative control for NVS-PAK1-1 , |
1 mg |
19965-1 |
More Info
|
NVS-PAK1-C |
A negative control for NVS-PAK1-1 , |
5 mg |
19965-5 |
More Info
|
NVS-ZP7-4 |
A ZIP7 inhibitor; induces apoptosis in TALL-1 cells; increases endoplasmic… |
1 mg |
33773-1 |
More Info
|
NVS-ZP7-4 |
A ZIP7 inhibitor; induces apoptosis in TALL-1 cells; increases endoplasmic… |
10 mg |
33773-10 |
More Info
|
NVS-ZP7-4 |
A ZIP7 inhibitor; induces apoptosis in TALL-1 cells; increases endoplasmic… |
25 mg |
33773-25 |
More Info
|
NVS-ZP7-4 |
A ZIP7 inhibitor; induces apoptosis in TALL-1 cells; increases endoplasmic… |
5 mg |
33773-5 |
More Info
|
NXY-059 |
A nitrone free radical spin trap with neuroprotective properties; inhibits… |
10 mg |
22109-10 |
More Info
|
NXY-059 |
A nitrone free radical spin trap with neuroprotective properties; inhibits… |
25 mg |
22109-25 |
More Info
|
NXY-059 |
A nitrone free radical spin trap with neuroprotective properties; inhibits… |
5 mg |
22109-5 |
More Info
|
NXY-059 |
A nitrone free radical spin trap with neuroprotective properties; inhibits… |
50 mg |
22109-50 |
More Info
|
Nybomycin |
A fungal metabolite with antibacterial activity; active against B. subtili… |
2.5 mg |
28099-25 |
More Info
|
Nybomycin |
A fungal metabolite with antibacterial activity; active against B. subtili… |
500 µg |
28099-500 |
More Info
|
Nylidrin |
An agonist of β-ARs and antagonist of NR1A / 2B subunit-containing NM… |
10 mg |
33232-10 |
More Info
|